Forty Years After Introduction, Breast Cancer Prevention Drug Still Effective
Nearly 40 years after its introduction, tamoxifen continues to prove its value as a breast cancer prevention drug. The most recent evidence comes from the International Breast Cancer Prevention Study 1 (IBIS-1), which for 20 years has been tracking breast cancer occurrence and survival rates in more than 7,000 women who had a higher than average … Read more